AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Edwards Lifesciences Corp Director's Dealing 2011

May 10, 2011

30042_dirs_2011-05-10_fdbeddc6-2b02-4ea3-aac7-617b3522b19f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2011-05-09

Reporting Person: Abate Thomas M (CVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-09	Common Stock	S	2185.0000	$88.2000	Disposed	47018.0000	Direct
2011-05-10	Common Stock	S	2668.0000	$88.0700	Disposed	44350.0000	Direct

Footnotes

F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.